Body mass index and insulin use as identifiers of high-cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data.

Stephen S JohnstonEric M AmmannSangeetha R KashyapAndrew StokesCarine Chia-Wen HsiaoMehmet DaskiranRobin Scamuffa

Published in: Diabetes, obesity & metabolism (2019)

BMI and insulin use represent simple stratifiers for identifying high-cost patients. OCIII insulin users incurred the greatest annual healthcare expenditures; these patients may be an ideal group for targeted interventions.

Keyphrases

electronic health record
end stage renal disease
type diabetes
healthcare
ejection fraction
chronic kidney disease
newly diagnosed
health insurance
body mass index
patient reported outcomes
social media
clinical decision support
insulin resistance